Correlation Between Crinetics Pharmaceuticals and Moleculin Biotech
Can any of the company-specific risk be diversified away by investing in both Crinetics Pharmaceuticals and Moleculin Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crinetics Pharmaceuticals and Moleculin Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crinetics Pharmaceuticals and Moleculin Biotech, you can compare the effects of market volatilities on Crinetics Pharmaceuticals and Moleculin Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crinetics Pharmaceuticals with a short position of Moleculin Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crinetics Pharmaceuticals and Moleculin Biotech.
Diversification Opportunities for Crinetics Pharmaceuticals and Moleculin Biotech
0.13 | Correlation Coefficient |
Average diversification
The 3 months correlation between Crinetics and Moleculin is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Crinetics Pharmaceuticals and Moleculin Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moleculin Biotech and Crinetics Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crinetics Pharmaceuticals are associated (or correlated) with Moleculin Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moleculin Biotech has no effect on the direction of Crinetics Pharmaceuticals i.e., Crinetics Pharmaceuticals and Moleculin Biotech go up and down completely randomly.
Pair Corralation between Crinetics Pharmaceuticals and Moleculin Biotech
Given the investment horizon of 90 days Crinetics Pharmaceuticals is expected to under-perform the Moleculin Biotech. But the stock apears to be less risky and, when comparing its historical volatility, Crinetics Pharmaceuticals is 3.01 times less risky than Moleculin Biotech. The stock trades about 0.0 of its potential returns per unit of risk. The Moleculin Biotech is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 262.00 in Moleculin Biotech on August 29, 2024 and sell it today you would earn a total of 0.00 from holding Moleculin Biotech or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Crinetics Pharmaceuticals vs. Moleculin Biotech
Performance |
| Timeline |
| Crinetics Pharmaceuticals |
| Moleculin Biotech |
Crinetics Pharmaceuticals and Moleculin Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Crinetics Pharmaceuticals and Moleculin Biotech
The main advantage of trading using opposite Crinetics Pharmaceuticals and Moleculin Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crinetics Pharmaceuticals position performs unexpectedly, Moleculin Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moleculin Biotech will offset losses from the drop in Moleculin Biotech's long position.| Crinetics Pharmaceuticals vs. Viridian Therapeutics | Crinetics Pharmaceuticals vs. Cytokinetics | Crinetics Pharmaceuticals vs. Structure Therapeutics American | Crinetics Pharmaceuticals vs. Passage Bio |
| Moleculin Biotech vs. Bright Minds Biosciences | Moleculin Biotech vs. HP Inc | Moleculin Biotech vs. Intel | Moleculin Biotech vs. Chevron Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |